rozersmith021According to IMARC Group’s latest report, titled “Virus Filtration Market: Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027,” the global virus filtration market reached a value of US$ 3.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2027, exhibiting at a CAGR of 11.2% during 2022-2027.
Virus filtration refers to a robust and effective virus clearance technology used in the manufacturing of biological therapeutics and plasma-derived product drug substances. It consists of a polymeric membrane barrier to retain virus particles on the surface and within the pores of the membrane from biotech and plasma processes. It provides a critical defense mechanism against the introduction of adventitious viruses into a different class of medicines.
Request Free Sample Report: https://www.imarcgroup.com/virus-filtration-market/requestsample
Market Trends
Biological therapeutic products are generally produced using mammalian cell lines or human plasma, which increases the risk of contamination. This, in confluence with the rising need for therapeutic products on account of the growing prevalence of chronic diseases, represents one of the key factors driving the demand for virus filtration solutions across the globe. Apart from this, governing agencies of numerous countries are implementing stringent regulations to ensure the virological safety of biological therapeutics. This is encouraging pharmaceutical manufacturers to integrate virus filtration methods to evaluate and mitigate the risks of virus contamination.
Ask Analyst and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/virus-filtration-market
List of Key Companies Covered in this Market Report:
- Asahi Kasei Medical Co. Ltd.
- Charles River Laboratories Inc.
- Clean Cells
- Danaher Corporation
- Merck KGaA
- Sartorius AG,
- Thermo Fisher Scientific Inc.
The report has segmented the market on the basis of product, application, end use and geography.
Breakup by Product:
- Consumables
- Kits and Reagents
- Others
- Instruments
- Filtration Systems
- Chromatography Systems
- Services
Breakup by Application:
- Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Others
- Medical Devices
- Water Purification
- Air Purification
- Others
Breakup by End Use:
- Biopharmaceuticals and Biotechnology Companies
- Contract Research Organizations
- Academic Institutes and Research Laboratories
- Others
Breakup by Geography:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Contact US
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Website: https://www.imarcgroup.com/
Follow us on Twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
